Shigella infections in children: New insights

Keyphrases

• 5-year-old 16%
• Acute Enteric Infections 16%
• Annual Incidence 16%
• Antimicrobial Resistance 16%
• Appropriate Antibiotic Therapy 16%
• Bacteremia 16%
• Bacterial Virulence Factors 16%
• Children Younger than 5 Years 16%
• Clinical Characteristics 16%
• Clinical Symptoms 16%
• Colonic mucosa 16%
• Developing Countries 16%
• Electrolyte Loss 16%
• Extraintestinal Complications 16%
• Fecal Excretion 16%
• Fluid Loss 16%
• Host Response 16%
• Infections in children 100%
• Innovative Therapies 16%
• Molecular Mechanism 16%
• Neonatal Period 16%
• Neurological Manifestations 16%
• Oral Rehydration Solution 16%
• Pathophysiology 33%
• Shigella 100%
• Shigellosis 100%
• Surgical Complications 16%
• Symptom Manifestations 16%
• Therapeutic Approaches 16%
• United States 16%
• Urogenital Symptoms 16%
• Vaccine Candidate 16%
• Worldwide Distribution 16%

Medicine and Dentistry

• Antibiotic Resistance 16%
• Antibiotic Therapy 16%
• Bacillary Dysentery 100%
• Bacteremia 16%
• Bacterial Virulence 16%
• Colon Mucosa 16%
• Disease 16%
• Immune Response 16%
• Infection 100%
• Intestine Infection 16%
• Neurologic Disease 16%
• Newborn Period 16%
• Pathogen 16%
• Pathophysiology 33%
• Pedialyte 16%
• Postoperative Complication 16%
• Shigella 100%
• Symptom 33%
• Toddlers 16%
• Virulence Factor 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Antibiotic Therapy 16%
• Antimicrobial Resistance 16%
• Bacteremia 16%
• Bacterial Virulence 16%
• Disease 16%
• Infection 100%
• Infectious Agent 16%
• Intestine Infection 16%
• Neurologic Disease 16%
• Oral Rehydration Solution 16%
• Pathophysiology 33%
• Postoperative Complication 16%
• Shigella 100%
• Shigellosis 100%
• Symptom 33%
• Virulence Factor 16%